These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 34847624)
1. Alnustone inhibits the growth of hepatocellular carcinoma via ROS- mediated PI3K/Akt/mTOR/p70S6K axis. Wang L; Cheng L; Ma L; Ahmad Farooqi A; Qiao G; Zhang Y; Ye H; Liu M; Huang J; Yang X; Lin X; Cao S Phytother Res; 2022 Jan; 36(1):525-542. PubMed ID: 34847624 [TBL] [Abstract][Full Text] [Related]
2. Comment on: Alnustone inhibits the growth of hepatocellular carcinoma via reactive oxygen species-mediated PI3K/Akt/mTOR/p70S6K axis. Li Z Phytother Res; 2023 Jun; 37(6):2215-2216. PubMed ID: 36560899 [No Abstract] [Full Text] [Related]
3. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway. Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227 [TBL] [Abstract][Full Text] [Related]
4. SB365 inhibits angiogenesis and induces apoptosis of hepatocellular carcinoma through modulation of PI3K/Akt/mTOR signaling pathway. Hong SW; Jung KH; Lee HS; Choi MJ; Son MK; Zheng HM; Hong SS Cancer Sci; 2012 Nov; 103(11):1929-37. PubMed ID: 22909393 [TBL] [Abstract][Full Text] [Related]
5. Luteoloside induces G Zhou M; Shen S; Zhao X; Gong X Biochem Biophys Res Commun; 2017 Dec; 494(1-2):263-269. PubMed ID: 29024631 [TBL] [Abstract][Full Text] [Related]
6. Itraconazole exerts anti-liver cancer potential through the Wnt, PI3K/AKT/mTOR, and ROS pathways. Wang W; Dong X; Liu Y; Ni B; Sai N; You L; Sun M; Yao Y; Qu C; Yin X; Ni J Biomed Pharmacother; 2020 Nov; 131():110661. PubMed ID: 32942154 [TBL] [Abstract][Full Text] [Related]
7. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway. Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943 [TBL] [Abstract][Full Text] [Related]
8. Preclinical efficacy of a novel dual PI3K/mTOR inhibitor, CMG002, alone and in combination with sorafenib in hepatocellular carcinoma. Kim MN; Lee SM; Kim JS; Hwang SG Cancer Chemother Pharmacol; 2019 Oct; 84(4):809-817. PubMed ID: 31385002 [TBL] [Abstract][Full Text] [Related]
9. Lappaconitine Sulfate Inhibits Proliferation and Induces Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells through the Reactive Oxygen Species-Dependent Mitochondrial Pathway. Zhang X; Ma J; Song N; Guo Y; Hui L; Sang C Pharmacology; 2020; 105(11-12):705-714. PubMed ID: 32062649 [TBL] [Abstract][Full Text] [Related]
10. Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells. Grabinski N; Ewald F; Hofmann BT; Staufer K; Schumacher U; Nashan B; Jücker M Mol Cancer; 2012 Nov; 11():85. PubMed ID: 23167739 [TBL] [Abstract][Full Text] [Related]
11. 13-Acetoxysarcocrassolide induces apoptosis in human hepatocellular carcinoma cells through mitochondrial dysfunction and suppression of the PI3K/AKT/mTOR/p70S6K signalling pathway. Hsu CM; Lin JJ; Su JH; Liu CI Pharm Biol; 2022 Dec; 60(1):2276-2285. PubMed ID: 36416062 [TBL] [Abstract][Full Text] [Related]
12. The (+)-Brevipolide H Displays Anticancer Activity against Human Castration-Resistant Prostate Cancer: The Role of Oxidative Stress and Akt/mTOR/p70S6K-Dependent Pathways in G1 Checkpoint Arrest and Apoptosis. Sheng YH; Leu WJ; Chen CN; Hsu JL; Liu YT; Hsu LC; Hou DR; Guh JH Molecules; 2020 Jun; 25(12):. PubMed ID: 32630532 [TBL] [Abstract][Full Text] [Related]
13. Ovatodiolide and antrocin synergistically inhibit the stemness and metastatic potential of hepatocellular carcinoma via impairing ribosome biogenesis and modulating ERK/Akt-mTOR signaling axis. Chen MY; Hsu CH; Setiawan SA; Tzeng DTW; Ma HP; Ong JR; Chu YC; Hsieh MS; Wu ATH; Tzeng YM; Yeh CT Phytomedicine; 2023 Jan; 108():154478. PubMed ID: 36265255 [TBL] [Abstract][Full Text] [Related]
14. Coptisine induces autophagic cell death through down-regulation of PI3K/Akt/mTOR signaling pathway and up-regulation of ROS-mediated mitochondrial dysfunction in hepatocellular carcinoma Hep3B cells. Kim SY; Hwangbo H; Kim MY; Ji SY; Lee H; Kim GY; Kwon CY; Leem SH; Hong SH; Cheong J; Choi YH Arch Biochem Biophys; 2021 Jan; 697():108688. PubMed ID: 33227289 [TBL] [Abstract][Full Text] [Related]
15. IL-37 induces autophagy in hepatocellular carcinoma cells by inhibiting the PI3K/AKT/mTOR pathway. Li TT; Zhu D; Mou T; Guo Z; Pu JL; Chen QS; Wei XF; Wu ZJ Mol Immunol; 2017 Jul; 87():132-140. PubMed ID: 28433890 [TBL] [Abstract][Full Text] [Related]
17. Hydrogen sulfide promotes autophagy of hepatocellular carcinoma cells through the PI3K/Akt/mTOR signaling pathway. Wang SS; Chen YH; Chen N; Wang LJ; Chen DX; Weng HL; Dooley S; Ding HG Cell Death Dis; 2017 Mar; 8(3):e2688. PubMed ID: 28333142 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells. Yang J; Pi C; Wang G Biomed Pharmacother; 2018 Jul; 103():699-707. PubMed ID: 29680738 [TBL] [Abstract][Full Text] [Related]
19. Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma. Singh AR; Joshi S; Burgoyne AM; Sicklick JK; Ikeda S; Kono Y; Garlich JR; Morales GA; Durden DL Mol Cancer Ther; 2016 Nov; 15(11):2553-2562. PubMed ID: 27496136 [TBL] [Abstract][Full Text] [Related]
20. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway. Liu JS; Huo CY; Cao HH; Fan CL; Hu JY; Deng LJ; Lu ZB; Yang HY; Yu LZ; Mo ZX; Yu ZL Phytomedicine; 2019 Aug; 61():152843. PubMed ID: 31039533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]